1. Home
  2. Analysis
  3. Metoprolol-tartrate
  4. Xywav

Metoprolol tartrate and Xywav drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 36 people who take Metoprolol tartrate and Xywav. Common interactions include knee arthroplasty among females, and dizziness among males.

The phase IV clinical study analyzes what interactions people who take Metoprolol tartrate and Xywav have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

36 people who take Metoprolol tartrate and Xywav together, and have interactions are studied.

What is Metoprolol tartrate?

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is used in high blood pressure. Currently, eHealthMe is studying from 86,266 Metoprolol tartrate users.

What is Xywav?

Xywav has active ingredients of calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate. Currently, eHealthMe is studying from 4,474 Xywav users.

Number of Metoprolol tartrate and Xywav reports submitted per year:

Metoprolol tartrate and Xywav drug interactions.

Common Metoprolol Tartrate and Xywav drug interactions by gender *:

female:

  1. Knee arthroplasty
  2. Nasopharyngitis
  3. Osteoarthritis
  4. Pancreatitis
  5. Restless legs syndrome
  6. Seizure
  7. Sleep apnoea syndrome
  8. Diarrhoea
  9. Drug hypersensitivity
  10. Fractured coccyx

male:

  1. Dizziness
  2. Pain
  3. Discomfort
  4. Euphoric mood
  5. Fall
  6. Food allergy
  7. Hallucination
  8. Head injury
  9. Incontinence
  10. Loss of consciousness

Common Metoprolol Tartrate and Xywav drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Gait disturbance
  2. Hallucination
  3. Headache
  4. Nervousness
  5. Nightmare
  6. Diarrhoea
  7. Hypotension
  8. Migraine
  9. Pain in extremity
  10. Terminal insomnia

40-49:

  1. Contusion
  2. Crying
  3. Discomfort
  4. Dysphonia
  5. Dyspnoea
  6. Ear infection
  7. Face injury
  8. Fall
  9. Headache
  10. Hospitalisation

50-59:

  1. Hospitalisation
  2. Pancreatitis
  3. Restless legs syndrome
  4. Somnolence

60+:

  1. Dizziness
  2. Infection
  3. Raynaud's phenomenon
  4. Upper limb fracture

Common conditions people have *:

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 29 people, 80.56%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 27 people, 75.00%
  3. Drowsiness: 26 people, 72.22%
  4. Migraine (headache): 2 people, 5.56%
  5. Insomnia (sleeplessness): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Metoprolol tartrate and Xywav?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Metoprolol tartrate drug interactions:

Browse interactions between Metoprolol tartrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Xywav drug interactions:

Browse interactions between Xywav and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on metoprolol tartrate and calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate (the active ingredients of Metoprolol tartrate and Xywav, respectively), and Metoprolol tartrate and Xywav (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Metoprolol tartrate and Xywav.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.